(Q24201930)

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Duration and severity of symptoms and levels of plasma interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Failure of zinc gluconate in treatment of acute upper respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Zinc combined with vitamin A reduces upper respiratory tract infection morbidity in a randomised trial in preschool children in Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

An open-label, single-center, phase IV clinical study of the effectiveness of zinc gluconate glycine lozenges (Cold-Eeze) in reducing the duration and symptoms of the common cold in school-aged subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Use of zinc supplements to reduce upper respiratory infections in United States Air Force Academy cadets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Treatment of naturally acquired common colds with zinc: a structured review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

The Common Cold: Control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Zinc lozenges: cold cure or candy? Solution chemistry determinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Zinc lozenges as cure for the common cold--a review and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

The problems of taste in placebo matching: an evaluation of zinc gluconate for the common cold

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

The economic burden of non-influenza-related viral respiratory tract infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

In vitro activity of zinc salts against human rhinoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Zinc lozenges may shorten the duration of colds: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Efficacy of zinc against common cold viruses: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Copper and zinc inhibit the metabolism of prostaglandin by the human uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Quantitative synthesis in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

How does zinc modify the common cold? Clinical observations and implications regarding mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Virus, toxin, complement: common actions and their prevention by Ca2+ or Zn2+.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

The treatment of rhinovirus infections: progress and potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Zinc(II) in saliva: determination of concentrations produced by different formulations of zinc gluconate lozenges containing common excipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Zinc for the common cold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

21 January 2018

Zinc for the common cold

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

7 January 2021

Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

7 January 2021

Rhinovirus infections in an industrial population. I. The occurrence of illness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

7 January 2021

The prophylactic and therapeutic effectiveness of zinc sulphate on common cold in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

7 January 2021

Zinc and the common cold: a meta-analysis revisited

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

7 January 2021

Effect of zinc sulfate on common cold in children: randomized, double blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

7 January 2021

Zinc gluconate and the common cold: a controlled clinical study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

7 January 2021

The mouth-nose biologically closed electric circuit in zinc lozenge therapy of common colds as explanation of rapid therapeutic action

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

7 January 2021

Zinc lozenges for the common cold.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001364.PUB4

7 January 2021

Zinc ion availability--the determinant of efficacy in zinc lozenge treatment of common colds

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

A simple method for converting an odds ratio to effect size for use in meta-analysis

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

ORAL ZINC SULPHATE IN RHEUMATOID ARTHRITIS

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

Random-effects meta-analyses are not always conservative.

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

Dichotomizing continuous predictors in multiple regression: a bad idea

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

Elimination of efficacy by additives in zinc acetate lozenges for common colds

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

Intranasal zinc and anosmia: the zinc-induced anosmia syndrome

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

Replication of rhinoviruses

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

Characterization of the large picornaviral polypeptides produced in the presence of zinc ion.

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

Zinc ions inhibit replication of rhinoviruses

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

Serum-zinc and healing of venous leg ulcers

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD001364.PUB4

10.1002/14651858.CD001364.PUB4

9 February 2024

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3406576

OpenCitations bibliographic resource ID

3406576

1 reference